The Company is a Taiwan-based company mainly provides design/development/production/sales services based on handheld medical nebulizers in accordance with the needs of pharmaceutical companies.
The products mainly include vibrating mesh nebulizers and contract development and manufacturing organization (CDMO) services for drug-specific nebulizers. The vibrating mesh nebulizer can adjust the oscillation frequency of the retina for different types of drugs, so that patients can successfully deliver drugs to the lower respiratory tract without training and specific breathing methods. The vibrating mesh nebulizer can be used to treat diseases such as chronic obstructive pulmonary disease, asthma, cystic fibrosis, and respiratory tract infections. The CDMO service for drug-specific nebulizers provides special nebulizers for inhalation dosage form design and development. The products are mainly sold in the United States, Taiwan, Switzerland, Israel, and the United Kingdom.
History
The Company was established on October 6, 2014 .The Company was listed on PUBLIC COMPANIES on October 24, 2022. The Company was listed on EMERGING STOCKS on June 25, 2024.
Headquarters
10F., No.319, Sec.2, Dunhua S Rd
Taipei City; Taipei City;
Contact Details: Purchase the Hcmed Innovations Co. Ltd. report to view the information.
Website: http://www.hcmed-inno.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service